Gillian
Gillian Butler-Browne, Paris FR
Patent application number | Description | Published |
---|---|---|
20120258093 | VLA-4 AS A BIOMARKER FOR PROGNOSIS AND TARGET FOR THERAPY IN DUCHENNE MUSCULAR DYSTROPHY - The invention relates to methods for the treatment of Duchenne muscular dystrophy and to methods for determining the prognosis of a subject affected with Duchenne Muscular Dystrophy. More particularly, the present invention relates to a VLA-4 antagonist for use in the treatment of Duchenne Muscular Dystrophy. The present invention also relates to a method for determining the prognosis of a subject affected with Duchenne Muscular Dystrophy wherein said method comprising a step consisting of determining the level of VLA-4 high T cells in a blood sample obtained from said subject. | 10-11-2012 |
Gillian Clark, Auckland NZ
Patent application number | Description | Published |
---|---|---|
20100137200 | METHODS FOR TREATMENT OF GROWTH DISORDERS - The present invention provides methods and compositions for increasing the growth rates, alleviating the symptoms, or improving the metabolism of human patients having an endocrine disorder characterized by partial endogenous growth hormone activity or signaling. The invention provides a method comprising administering to a patient suffering from an endocrine disorder characterized by partial endogenous growth hormone activity or signaling an amount of insulin-like growth factor-1 (IGF-1) effective to improve metabolism in the patient, where the patient receives IGF-1 in a single daily administration. The invention also provides a method comprising administering to a patient suffering from an endocrine disorder characterized by partial endogenous growth hormone activity or signaling an amount of insulin-like growth factor-1 (IGF-1) and an amount of growth hormone (GH) that in combination are effective to improve growth or metabolism in the patient, where the patient receives IGF-1 in a single daily administration and receives GH in a single daily administration, and where the single IGF-1 administration and the single GH ad-ministration are administered to the patient substantially contemporaneously each day. | 06-03-2010 |
Gillian Escandell, Nice FR
Patent application number | Description | Published |
---|---|---|
20090293844 | Pressure-controlling electromagnetic valve for distinct electromagnetic and hydraulic units - The pressure controlling electromagnetic valve comprises an electric sub-assembly ( | 12-03-2009 |
20100194504 | Electromagnetic actuator comprising a magnetic tube and used for actuating a hydraulic or pneumatic valve - The electromagnetic actuator comprises an electric coil ( | 08-05-2010 |
Gillian Frette, Voorburg NL
Patent application number | Description | Published |
---|---|---|
20130020042 | DEBONDER AND SOFTENER COMPOSITIONS - Methods and compositions for softening paper. An inventive composition and method of its use softens paper products (like tissue paper) by de-bonding its cellulose fibers and by improving the smoothness of the resulting paper. The invention forms a surfactant-polymer complex that attaches de-bonding non-ionic surfactants to cellulose fibers that would otherwise not be retained by the cellulose fibers. This complex prevents the fibers from bonding with each other and makes the paper product smoother. Best of all, the composition is environmentally superior and is a non-toxic. | 01-24-2013 |
20130340963 | DEBONDER AND SOFTENER COMPOSITIONS - The invention provides methods and compositions for softening paper. An inventive composition and method of its use softens paper products (like tissue paper) by de-bonding its cellulose fibers and by improving the smoothness of the resulting paper. The invention forms a surfactant-polymer complex that attaches de-bonding non-ionic surfactants to cellulose fibers that would otherwise not be retained by the cellulose fibers. This complex prevents the fibers from bonding with each other and makes the paper product smoother. Best of all, the composition is environmentally superior and is a non-toxic. | 12-26-2013 |
Gillian Lachelin, Ockham, Surrey GB
Patent application number | Description | Published |
---|---|---|
20120157422 | MARKER - The invention provides a method for identifying whether a pregnant subject has an increased risk of preterm labour comprising measuring the progesterone concentration in a sample obtained from the subject, wherein a reduced progesterone concentration is indicative of an increased risk of preterm labour and delivery. | 06-21-2012 |
Gillian Leigh Blakeney, Pacific Palisades, CA US
Patent application number | Description | Published |
---|---|---|
20150305087 | Automatically Adjustable Projector with Wireless Data Stream - The invention is directed toward a system and method for transferring and projecting audiovisual files from a wireless device to a projector. The system and method is further directed toward a unique method of manipulating images on a wireless device and projecting the manipulated images from the projector. The system comprises a wireless device and projector with a movable projector head. The wireless device transmits an audiovisual file to the projector. As the wireless device is repositioned, the movable projector head on the projector moves in response. A user can control the angle of projection by changing the angle of the wireless device. A user can also manipulate the image of the audiovisual file on the touch screen display of the wireless device. The changes in the image are transmitted to the projector and the projector projects the changed image. | 10-22-2015 |
Gillian Martinez Donato, Ciudad De La Habana CU
Patent application number | Description | Published |
---|---|---|
20100316669 | VACCINE FORMULATION POTENTIATED BY THE COMBINATION OF DNA AND AN ANTIGEN - Formulation of vaccine antigens, containing as main components: a-) one or several DNA expressing one or several proteins in the immunized individuals and b-) a viral antigen, in appropriate proportions. Development of new formulations, minimizing the number of components that enhance and diversify the spectrum of immune response against different pathogenic entities and generating combined vaccines against pathogens. | 12-16-2010 |
Gillian MartÃnez Donato, La Habana CU
Patent application number | Description | Published |
---|---|---|
20150307558 | CHIMERIC VACCINE ANTIGENS AGAINST HEPATITIS C VIRUS - The invention relates to chimeric vaccine antigens against hepatitis C virus (HCV) comprising selected regions of different antigens of said virus, which are placed in a pre-determined order inside the polypeptide. In addition, said chimeric antigens can include artificially formed specific epitopes for auxiliary T helper lymphocytes. The chimeric antigens and the resulting vaccine compositions are suitable for use in medicine and the pharmaceutical industry, as well as being suitable for prophylactic and/or therapeutic use against HCV. The vaccine compositions of the invention generate a powerful, broad-spectrum immune response against different antigens of the virus, with a minimum number of components. | 10-29-2015 |
Gillian Reid, Southampton GB
Patent application number | Description | Published |
---|---|---|
20150329983 | PROCESS FOR THE ELECTROCHEMICAL DEPOSITION OF A SEMICONDUCTOR MATERIAL - A process for the electrochemical deposition of a semiconductor material, which process comprises: (i) providing a non-aqueous solvent; (ii) providing at least one precursor salt which forms a source of the constituent elements within the semiconductor material to be deposited; and (iii) electrodepositing the semiconductor material onto an electrode substrate using the precursor salt in the non-aqueous solvent, characterised in that: (iv) the semiconductor material is a p-block or a post-transition metal semiconductor material containing at least one p-block element or post-transition metal; and (v) the non-aqueous solvent is a halocarbon non-aqueous solvent. | 11-19-2015 |
Gillian Teft, Maryburgh GB
Patent application number | Description | Published |
---|---|---|
20110077493 | ANALYTE TESTING METHOD AND DEVICE FOR DIABETES MANGEMENT - Various embodiments are described and illustrated to calculate an insulin bolus, recommend such bolus, and provide reminder messages for performing an additional glucose test. | 03-31-2011 |
20110205064 | ANALYTE TESTING METHOD AND SYSTEM WITH HIGH AND LOW BLOOD GLUCOSE TRENDS NOTIFICATION - Described herein are systems and methods to utilize factual information based on stored blood glucose data to allow greater insight into the management of diabetes of a user. | 08-25-2011 |
20110205065 | ANALYTE TESTING METHOD AND SYSTEM WITH SAFETY WARNING FOR INSULIN DOSING - Methods and systems to provide for safeguards in the insulin dosing calculation as part of the diabetes management. The system or method provides a warning if the person with diabetes is calculating a dosing regimen outside of a preselected time period in which certain dosing parameters are customized to the preselected time period. | 08-25-2011 |
Gillian White, Basingstoke GB
Patent application number | Description | Published |
---|---|---|
20140358705 | CONTROL OF VENDING MACHINES - Methods and apparatus for control of vending machines by a user equipment. The methods and apparatus comprise a user device comprising an identification unit configured to obtain data identifying a vending machine from an identification unit of the vending machine. The user device further comprises a communication unit configured to query a database to obtain data relating to the content of the identified vending machine, and a user interface configured to present the obtained data to a user and to receive a user input relating to the content of the identified vending machine. The communication unit of the user device is configured to transmit to the database updated data based on the user input and relating to the content of the vending machine. | 12-04-2014 |